International law firm Dorsey & Whitney LLP announced today that it represented long-time client Vascular Solutions, Inc. (Nasdaq: VASC) in a definitive agreement to be acquired by Teleflex Incorporated (NYSE: TFX) for a purchase price of $56 per share in cash (or $1.0 billion in the aggregate), representing a 16% premium over the average closing price during the 90-trading-day period ended December 1.
Vascular Solutions is an innovative medical device company that focuses on developing unique clinical solutions for coronary and peripheral vascular procedures. Since its founding in 1997, the company has launched more than 100 products that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein specialists through its direct U.S. sales force and international independent distributor network.
A Dorsey team led by Minneapolis Corporate Partners Jonathan Van Horn and Tim Hearn represented Vascular Solutions in its sale to Teleflex, which is subject to shareholder approval and customary closing conditions and is expected to close during the first half of 2017. Other members of the Dorsey team included: Partners Joe Genereux, Ben Lindblad and Michael Lindsay and Associates Violet Richardson, Adam Wickens and Jamie Klang.
Dorsey Represents Vascular Solutions, Inc. in Acquisition by Teleflex Incorporated
December 6, 2016